Amy Wakeham | VP, IR & Corporate Communications |
Michael Farrell | CEO & Director |
Brett Sandercock | CFO |
Robert Douglas | President, COO and Interim President, Sleep & Respiratory Care |
Craig Wong-Pan | RBC Capital Markets |
Sean Laaman | Morgan Stanley |
Margarate Boeye | William Blair & Company |
David Bailey | Macquarie Research |
Michael Matson | Needham & Company |
Lyanne Harrison | Bank of America Merrill Lynch |
Steven Wheen | Jarden Limited |
David Low | JPMorgan Chase & Co. |
Saul Hadassin | Barrenjoey Capital |
Gretel Janu | Crédit Suisse |
Suraj Kalia | Oppenheimer |
Matthew Mishan | KeyBanc Capital Markets |
Chris Cooper | Goldman Sachs Group |
Dan Hurren | MST Marquee |
Hello and welcome to the Q4 Fiscal Year 2022 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call. [Operator Instructions]. Please note that this conference is being recorded. I will now turn the call over to Amy Wakeham, Vice President of Investor Relations and Corporate Communications.